片语

non-alcoholic steatosis hepatitis非酒精性脂肪性肝炎

Alcoholic Hepatitis AH酒精性肝炎

alcoholic steatosis hepatitis酒精性脂肪性肝炎

AH Alcoholic Hepatitis酒精性肝炎

acute alcoholic hepatitis急性酒精性肝炎

alcoholic c hepatitis酒精性肝炎

Non-alcoholic fatty hepatitis非酒精性脂肪性肝炎

英汉例句

• Hepatology Digest: Recently, the clinical trial result for the use of Etanercept for alcoholic hepatitis was published in Gastroenterology, and you were one of the authors.

  国际肝病：最近在胃肠病学杂志上发表了酒精性肝炎使用依那西普的临床试验结果，您是作者之一。

• The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids.

  里尔模型：类固醇为重度酒精性肝炎患者的治疗策略的新工具。

• Research results found a significantly higher rate of six-month mortality in patients with moderate to severe alcoholic hepatitis who received etanercept.

  研究结果发现接受依那西普的中重度酒精性肝炎患者的六个月死亡率显着增高。

• An increasing number of severely ill acute alcoholic hepatitis patients, often superimposed on cirrhosis, are being seen in our hospitals and cause much morbidity, mortality and health service costs.

  我在我们医院中看到越来越多的急性酒精性肝炎（日后大都转化为肝硬化）患者，他们会导致各种疾病的发病率和死亡率的升高，同时也消耗掉了许多宝贵的健康资源。

• Despite this treatment, 30-35% of patients with acute alcoholic hepatitis still die within a six month period, since the cortisone-based treatment remains insufficient.

  尽管这种治疗方法，但仍有30- 35%的急性酒精性肝炎患者死于六个月内，因为可的松为基础的治疗仍然效果不足。